Neuphoria Therapeutics (NEUP): Lynx1 Capital Pushes Board Shake-Up After Dilution, Missteps, and Failed Phase 3 Trial
Company Name: Neuphoria Therapeutics Inc.
Symbol: NEUP
Filing Date: Nov-26-2025
Filer Name: Lynx1 Capital Management LP
Download PresentationLynx1-11-26-2025.pdf7 MBdownload-circle
Orion Properties (ONL): The Kawa Fund nominates five directors in advance notice, launching proxy push.
Company Name: Orion Properties Inc.
Symbol: ONL
Filing Date: Nov-18-2025
Filer Name: Kawa Capital Management, Inc
Download Nomination LetterNotice of
Neuphoria Therapeutics (NEUP): Lynx1 withdraws $5.20 bid, blasts dilutive ATM issuances.
November 18, 2025
The Board of Directors of Neuphoria Therapeutics Inc.
100 Summit Drive
Burlington, Massachusetts 01803
Dear Members of
Tiptree Inc. (TIPT): Veradace Partners LP challenges strategy in new presentation, pressing for governance and capital allocation improvements
Company Name: Tiptree Inc.
Symbol: TIPT
Filing Date: Nov-17-2025
Filer Name: Veradace Partners LP
Download PresentationVeradace-Nov-17-2025.pdf5 MBdownload-circle
Source:
https:
Silver Star Properties (SLVS): Hartman Shareholder Alliance accuses board of “value destruction” after court denies meeting delay
The Pattern Continues: More Value Destruction
November 17, 2025
Dear Shareholder,
After six postponements of your court-ordered shareholder meeting and
Novavax (NVAX): Shah Capital Slams Leadership Over Market Share Collapse, Costs, and Governance Failures
November 12, 2025
Board of Directors of Novavax Inc.
21 Firstfield Rd.
Gaithersburg, MD 20878
As ~8.3% shareholder, Shah
Member discussion